Accepting applications: Operational research to support the elimination of communicable diseases in the Latin America and Caribbean Region

Accepting applications: Operational research to support the elimination of communicable diseases in the Latin America and Caribbean Region
Operational research to support the elimination of communicable diseases in the Latin America and Caribbean Region

Deadline for submission: 10 October 2022 (23:59 EST)


The Pan American Health Organization (PAHO), jointly with the UNICEF/UNDP/World Bank/WHO Special Programme for Research and Training in Tropical Diseases (TDR), is pleased to announce the 2022–2023 Impact Grants for Regional Priorities call for applications for operational research to support the elimination of communicable diseases in the Latin America and Caribbean (LAC) Region.

Eligible countries: Only applicants from Latin America and the Caribbean are eligible.

Proposals may be submitted in English, Spanish or Portuguese.

Objective
Facilitate and strengthen public health-oriented operational research on selected communicable diseases that are potential candidates for elimination as a public health problem through an integrated approach.

Methodology and funding scope
Interventions and research questions within the scope of this call are listed in the document linked below. These have been selected based on a priority selection process undertaken by the PAHO Communicable Disease Department.

The funding is available for research only.

This PAHO/TDR call will not fund treatment and routine delivery of health services. Implementation and operational research activities supported by this call may be complementary to those supported by other stakeholders interested in the diseases and conditions covered in this call.

How to apply 
Applications should be submitted online no later than 10 October 2022 (23:59 EST) through the eTDR Community Site


Priority research areas by disease and health condition for this call for proposals 

Tuberculosis and other opportunistic infections in advanced HIV disease

  • Public health implementation of integrated testing of tuberculosis and other opportunistic infections such as histoplasmosis and cryptococcosis in people with advanced HIV disease.
  • Strategies to reduce mortality from tuberculosis and HIV opportunistic infections such as early identification, rapid screening, rapid initiation or prophylaxis.
  • Integrated models of care for tuberculosis and fungal opportunistic infections in advanced HIV disease based on WHO recommendations.

Sexually transmitted infections

  • Innovative strategies to identify sexually transmitted infections in key populations with special emphasis on Chlamydia trachomatis and Neisseria gonorrhoeae.
  • Design, implementation and evaluation of innovative models in contact tracing, linkage to care and case reporting to improve rates of treatment in STI partners.

Human T-lymphotropic virus infection (HTLV-1/2)

  • Design, pilot and evaluate an innovative model of care and service delivery in maternal and child health that address the prevention of MTCT of HTLV, with a public health approach and integrated with other diseases.
  • Cost-effectiveness studies of the implementation of public health policies for the prevention, diagnosis and care of HTLV (with a focus on mother-to-child transmission).
  • Evaluation and optimization of algorithms for the diagnosis of HTLV, aiming at reducing the cost of testing.
     

read more

Related Links